跳至主要内容
临床试验/NCT01769560
NCT01769560已完成不适用

MeFirst: A Tailored Intervention to HPV Vaccine Decision Making

University of Michigan2 个研究点 分布在 1 个国家目标入组 661 人开始时间: 2013年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
661
试验地点
2
主要终点
Determine the effect of the MeFirst tool, a tailored, online HPV vaccination decision-making guide, on HPV vaccination intention and/or uptake.

研究概览

简要总结

This study will test whether a tailored, online educational intervention increases HPV vaccine uptake and intent among female college students.

详细描述

MeFirst is the first web-based, online, educational tool designed to promote Human Papillomavirus (HPV) vaccine awareness and understanding in an effort to improve HPV vaccine intent and uptake among female university students. HPV is the most common sexually transmitted infection and causes genital warts and cancer. The HPV vaccine has been recommended for girls ages 11-26 since 2006, yet vaccination rates remain low. Tailored online interventions may be more effective tools to promote behavior change among college students than traditional static interventions. The proposed study is a randomized controlled trial testing the efficacy of the MeFirst tool vs. standard static educational material on increasing HPV vaccination intent and uptake among female university students aged 18-26.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Health Services Research
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 26 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • enrolled at the University of Michigan

排除标准

  • receipt of any doses of HPV vaccine

结局指标

主要结局

Determine the effect of the MeFirst tool, a tailored, online HPV vaccination decision-making guide, on HPV vaccination intention and/or uptake.

时间窗: Immediately post intervention, 3 months and 12 months

Intention will be assessed on a five-point scale immediately after and at 3 and 12 months. Uptake will be assessed by yes/no/don't know response to the statement, "I have received at least 1 dose of the HPV vaccine" at 3 and 12 months.

次要结局

  • Determine the effect of the MeFirst tool on HPV-related knowledge.(Immediately post intervention, 3 months and 12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Vanessa K. Dalton

Associate Professor

University of Michigan

研究点 (2)

Loading locations...

相似试验

MeFirst: A Tailored Intervention to HPV Vaccine... | 临床试验